Polmaforce 2mg Capsule

Polmaforce 2mg Capsule is a novel pain-relieving medication formulated with Polmacoxib, an active constituent belonging to the class of Selective Cyclooxygenase-2 (COX-2) inhibitors. This therapeutic classification makes it a targeted option for managing pain and inflammation associated with conditions like osteoarthritis. Its selective action on COX-2 enzymes helps minimise inflammation and discomfort without significantly affecting COX-1, reducing the likelihood of gastrointestinal side effects commonly associated with traditional NSAIDs. This medication is primarily used for conditions requiring long-term pain management, particularly in individuals where traditional NSAIDs may pose a higher risk of adverse effects. However, caution is essential when prescribing to individuals with a history of cardiovascular conditions, gastrointestinal bleeding, or severe liver or kidney impairment. To ensure safety, Polmaforce 2mg Capsule should only be used under medical supervision. Pregnant or breastfeeding women are advised to consult their healthcare provider before starting this medication. It is also contraindicated in individuals with known hypersensitivity to Polmacoxib or other NSAIDs. Adhering to the prescribed dosage and reporting any unusual symptoms can help optimise its benefits while minimising potential risks.